
Choisissez votre étiquette
affichée directement sur le flaconCabergoline
PCT & AI
- Expédié depuis l'Allemagne
Commande
- DHL avec suivi
- Emballage discret
4.6 sur 5 sur Trustpilot73 avis
Aussi recherché sous : Cabergolin
En un coup d'œil
Cabergoline en chiffres
Les chiffres clés de notre lexique. Faites glisser le point le long de la courbe pour voir ce qui reste après une dose, par calcul.
Article complet du lexiqueHow long does it stay in the body?
Share left after one dose, calculated with a half-life of ~2.9 days
Simplified model without an absorption phase, half-life from the TPD lexicon.
Half-life
about70hours
- Class
- Dopamine D2 receptor agonist
- Use
- Oral1-2x per week
- Sizes
- 0.25 to 0.5 mg2 sizes in the shop
What studies show
All 3 sources in the lexicon- Webster et al., NEJM, 1994
- Pascal-Vigneron et al., Presse Med, 1995
- DailyMed, U.S. National Library of Medicine
Avis
Ce que disent les clients
Uniquement des commandes réelles qui contenaient Cabergoline.
Tous les avisIl n'existe pas encore d'analyse de laboratoire pour Cabergoline. Votez pourFaites-le tester vous-même, nous payons la moitiéToutes les analyses de laboratoire
Connaissances
Tout sur Cabergoline
Informations détaillées bientôt disponibles.
How does cabergoline lower prolactin?
Cabergoline binds as an agonist to the dopamine D2 receptor. Dopamine is the natural brake on the prolactin cells in the pituitary. According to the label it has only low affinity for other receptors such as D1, alpha adrenoceptors and serotonin receptors.
Is cabergoline approved?
Yes. ChEMBL lists cabergoline as an approved compound with first approval in 1996. On ClinicalTrials.gov 83 trials list cabergoline (as of 26 October 2026). Everything here is the state of research, not a recommendation.
Is it better than bromocriptine?
In the large comparison trial with 459 women yes: prolactin was stably normal in 83 instead of 59 percent, 72 instead of 52 percent ovulated or became pregnant. Side effects occurred in 68 instead of 78 percent, 3 instead of 12 percent stopped. A French trial with 120 women came to the same result.
What about the heart valves?
The label requires a heart ultrasound before starting and checks every 6 to 12 months. Valve changes occurred mostly at high doses in Parkinson's treatment, but there are also cases at lower doses. In a cohort study in Parkinson's the rate was 68 per 10,000 person-years, with other drugs 10 to 11.
Why dizziness on standing?
Cabergoline can lower blood pressure, especially when standing up quickly. In the placebo-controlled trial 15 percent had dizziness and 4 percent a drop in blood pressure on standing, 5 and 0 percent on placebo. The label advises checking blood pressure at the start and during use.
Can cabergoline affect behaviour?
Yes, the label lists impulse control disorders: new or stronger urges to gamble, increased sexual urges, uncontrolled spending and binge eating. Anyone noticing this should raise it with a doctor.
Which trials are running right now?
As of 26 October 2026 recruiting trials include a phase 3 trial with 382 planned participants against bromocriptine, a phase 3 trial on the safety of a higher dose in microprolactinomas and a phase 4 trial on metabolism in prolactinomas.
Produits associés
Produits similaires
Clomid (Clomifen)
Médicaments · Post-cycle & inhibiteurs de l'aromatase Post-cycle & inhibiteurs de l'aromatase
2 tailles
Tamoxifen (Nolvadex)
Médicaments · Post-cycle & inhibiteurs de l'aromatase Post-cycle & inhibiteurs de l'aromatase
2 tailles
Testé en laboratoire
Aromasin (Exemestane)
Médicaments · Post-cycle & inhibiteurs de l'aromatase Post-cycle & inhibiteurs de l'aromatase
2 tailles
Arimidex (Anastrozole)
Médicaments · Post-cycle & inhibiteurs de l'aromatase Post-cycle & inhibiteurs de l'aromatase
2 tailles
Cabergoline